Primary solitary fibrous tumour in the pulmonary artery: a case report

This report presents a very rare case of fibrous tumour in the pulmonary artery. A 32-year-old male patient presented at the First Hospital of Jilin University with the chief complaint of chest pain accompanied by cough and haemoptysis. Laboratory test results showed a D-dimer level of 60 ng/ml, and...

Full description

Saved in:
Bibliographic Details
Published in:Journal of international medical research 2020-03, Vol.48 (3), p.300060520911273
Main Authors: Li, Bo, Mao, Miao-Miao, Adhikari, Binay Kumar, Li, Ze-Ya, Zhang, Wei-Hua
Format: Article
Language:English
Subjects:
Adult
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biomarkers, Tumor
Case Report
Case reports
Humans
Male
Multimodal Imaging - methods
Pulmonary arteries
Pulmonary Artery - pathology
Solitary Fibrous Tumors - diagnosis
Solitary Fibrous Tumors - therapy
Symptom Assessment
Vascular Neoplasms - diagnosis
Vascular Neoplasms - therapy
Veins & arteries
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This report presents a very rare case of fibrous tumour in the pulmonary artery. A 32-year-old male patient presented at the First Hospital of Jilin University with the chief complaint of chest pain accompanied by cough and haemoptysis. Laboratory test results showed a D-dimer level of 60 ng/ml, and protein S activity of 51.0%. Echocardiography and enhanced computed tomography (CT) of the lung revealed a thrombus-like mass in the main pulmonary artery trunk, and the left pulmonary artery and its branches. The patient was initially diagnosed with pulmonary embolism, but after performing arterial endarterectomy, the presence of a tumour in the corresponding areas was confirmed. Histopathology and immunohistochemistry indicated the presence of a malignant solitary fibrous tumour. Chemotherapeutic agents were administered following surgery. The patient was prescribed ongoing oral Apatinib (250 mg, once daily) as a tumour-targeting therapy. The patient refused permission for postoperative CT. The patient was still alive at the 2-year follow-up.
ISSN:0300-0605
1473-2300
DOI:10.1177/0300060520911273